Development of pharmaceuticals and contract manufacturing

pharm.dev

We offer services for the development of validation methods,
contract manufacturing, and dossier preparation
for the registration of medicines.



A multidisciplinary pharmaceutical
company specializing in contract manufacturing of medicinal products for EAEU countries.

папка

We will manufacture medicinal products
according to your regulatory
documents, and if they are absent, we will
develop them from scratch.

dna-image
папка

We will manufacture medicinal products
according to your regulatory
documents, and if they are absent, we will
develop them from scratch.

dna-imag

Our services

  • service-icon Development of medicinal products
  • service-icon Development of validation methods for medicinal products
  • service-icon Quality release control
  • service-icon Organization of contract manufacturing
  • service-icon Preparation of dossiers for registration in EAEU countries

We are

3
years in the Russian market
11
SKU
produced
6
dosage forms of medicinal products
4
manufacturing sites

Our production site is 'Celebritis Biopharm,' a group of companies consisting of 4 manufacturing sites in India with analytical and microbiological laboratories meeting international GMP standards.

Structure of work

Structure of work Structure of work

«Celebritis Biopharm» is the manufacturer of such drugs as

Remerus Sustilak Omeprazole Ibamol FluFight Remebrox

Types of work performed
and document preparation

  • Audit of API and excipient suppliers
  • Selection of materials for primary and secondary packaging
  • Manufacture of molds for tableting
  • Procurement and analysis of APIs and excipients for the production of 3 validation batches
  • Production of 3 validation batches of medicinal product
  • Obtaining quality certificates for APIs and excipients
  • Specifications and quality certification for primary and secondary packaging
  • Quality certificates for 3 validation batches of medicinal product
  • Preparation of DMF documents accompanying the API synthesis
  • Validation of methods for APIs:
    • Authenticity
    • Quantitative determination
    • Residual solvents
    • Related/other impurities
    • Dissolution
    • Microbiological purity
  • Validation of methods for finished medicinal products:
    • Specificity
    • Detection limit
    • Quantification limit
    • Linearity
    • Accuracy
    • Precision
    • Range of application (analytical area)
    • Robustness
  • Preparation of a technical module for finished dosage forms registration
  • Compilation of a dossier for the registration of medicinal products in the EAEU
  • Organization of a transport hub for product delivery